在控制性卵巢刺激中补充促黄体生成素:伊朗德尔菲共识

S. Salehpour, Ashraf Aleyasin, Ashraf Moini, Nezhat Mousavifar, Nasresfahani Mohammadhossein, Sedighe Abdollahi Fard, Sanuiefarimani Marzie, Mahboubeh Mohammadzadeh, Robert Fischer
{"title":"在控制性卵巢刺激中补充促黄体生成素:伊朗德尔菲共识","authors":"S. Salehpour, Ashraf Aleyasin, Ashraf Moini, Nezhat Mousavifar, Nasresfahani Mohammadhossein, Sedighe Abdollahi Fard, Sanuiefarimani Marzie, Mahboubeh Mohammadzadeh, Robert Fischer","doi":"10.3389/frph.2024.1397446","DOIUrl":null,"url":null,"abstract":"Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity.Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements.Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3′) obtained an 83% agreement.The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies.","PeriodicalId":503122,"journal":{"name":"Frontiers in Reproductive Health","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus\",\"authors\":\"S. Salehpour, Ashraf Aleyasin, Ashraf Moini, Nezhat Mousavifar, Nasresfahani Mohammadhossein, Sedighe Abdollahi Fard, Sanuiefarimani Marzie, Mahboubeh Mohammadzadeh, Robert Fischer\",\"doi\":\"10.3389/frph.2024.1397446\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity.Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements.Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3′) obtained an 83% agreement.The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies.\",\"PeriodicalId\":503122,\"journal\":{\"name\":\"Frontiers in Reproductive Health\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Reproductive Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/frph.2024.1397446\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Reproductive Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/frph.2024.1397446","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

全球有许多共识文件涉及在控制性卵巢刺激中补充黄体生成素(LH)的问题,但据我们所知,阿拉伯地区仅发表过一篇共识文件。本研究介绍了七位伊朗不孕不育专家达成的德尔菲共识,提供了真实世界的临床观点。目的是就 LH 与 FSH 在辅助生殖技术(ART)各方面的作用(包括 LH 水平、监测、r-hLH 的使用和建议的活动)形成基于证据的意见。采用德尔菲共识法,伊朗共识分三步展开。在第 1 步中,10 项陈述中有 8 项获得了认可,同时删除了两项不明确的陈述。在第 2 步中,由 20 名成员组成的扩大小组对其余 8 项声明进行了投票。只有一项声明(声明 3)未能达成共识(55% 的同意率),因此需要进行修改。修改后的声明(声明 3′)获得了 83% 的同意率。本共识中的临床观点是对临床指南和政策的补充,有助于进一步改善治疗效果,尤其是 FSH 和 LH 缺乏患者的治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Luteinizing hormone supplementation in controlled ovarian stimulation: the Iran Delphi consensus
Numerous consensus documents worldwide address luteinizing hormone (LH) supplementation in controlled ovarian stimulation, yet to the best of our knowledge, only one consensus paper has been published in the Arab region. This study presents a Delphi consensus by seven Iranian infertility experts, offering real-world clinical perspectives. The aim was to develop evidence-based opinions on LH's role alongside FSH in various aspects of assisted reproductive technology (ART), including LH levels, monitoring, r-hLH use, and suggested activity.Employing the Delphi consensus approach, the Iran consensus unfolded in three steps. In Step 1, eight out of 10 statements gained approval, while two unclear statements were removed. In Step 2, the 20-member extended panel voted on the remaining eight statements.Only one (statement 3) lacked consensus (55% agreement), prompting a modification. The revised statement (noted as statement 3′) obtained an 83% agreement.The clinical perspectives included in this consensus complement clinical guidelines and policies that help further improve treatment outcomes, especially for patients with FSH and LH deficiencies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信